-
Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart N – Servicing (§820.200) and Subpart O – Statistical Techniques (§820.250). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart M – Records (§820.180 General requirements, §820.181 Device master record, §820.184 Device history record, §820.186 Quality system record, §820.198 Complaint files). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart L – Handling, Storage, Distribution, and Installation (§820.140, §820.150, §820.160, §820.170). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart K – Labeling and Packaging Control (§820.120 Device labeling, §820.130 Device packaging). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart J – Corrective and Preventive Action (§820.100 CAPA). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart H – Acceptance Activities (§820.80 Receiving/in-process/finished device acceptance, §820.86 Acceptance status). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart E – Purchasing Controls (§820.50). Form 483 observations and Warning Letters 2017–2025.
FDA enforcement citation analysis for 21 CFR Part 820 Subpart F – Identification and Traceability (§820.60 Identification, §820.65 Traceability). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart G – Production and Process Controls (§820.70, §820.72 Inspection/measuring/test equipment, §820.75 Process validation). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart I – Nonconforming Product (§820.90). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart D – Document Controls (§820.40). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart C – Design Controls (§820.30). Form 483 observations and Warning Letters 2017–2025.Sale!
FDA enforcement citation analysis for 21 CFR Part 820 Subpart B – Quality System Requirements (§820.20 Management responsibility, §820.22 Quality audit, §820.25 Personnel). Form 483 observations and Warning Letters 2017–2025.Sale!
Comprehensive regulation-by-regulation analysis of FDA CFR Part 211 Subpart E (Control of Components and Drug Product Containers and Closures) with direct links to Form 483 observations and Warning Letters from 2017-2025.Sale!
Comprehensive laboratory controls enforcement data 2017-2025
Comprehensive holding and distribution enforcement data 2017-2025Sale!
Comprehensive packaging and labeling enforcement data 2017-2025Sale!
Comprehensive records and reports enforcement data 2017-2025Sale!
Comprehensive regulation-by-regulation analysis of FDA CFR Part 211 Subpart F (Production and Process Controls) with direct links to Form 483 observations and Warning Letters from 2017-2025.Sale!
Comprehensive regulation-by-regulation analysis of FDA CFR Part 211 Subpart D (Equipment) with direct links to Form 483 observations and Warning Letters from 2017-2025.
ComplyFDA delivers authoritative compliance intelligence for pharmaceuticals, medical devices, biologics, and combination products, giving your team the clarity needed to strengthen inspection readiness, evaluate compliance risks, and support continuous quality improvement.
services.
get in touch.
© 2012 - 2026 • Avada is a Website Builder for WordPress and eCommerce • All Rights Reserved • Developed by ThemeFusion
Go to Top
